glp-1 incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches GLP-1 Agonists: Increasing Effective Insulin

To view or add a comment, sign in Digital tools make it easier to reach members

**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program

Key Benefits: If your skin or joints need a boost, GHK-Cu is a copper peptide with strong regenerative and anti-inflammatory properties

Age-related macular degeneration: a disease of cellular senescence and dysregulated immune homeostasis

Pale straw to light yellow suggests adequate hydration

doi: 10.1016/j.neuropharm.2018.11.002 [DOI] [PubMed] [Google Scholar] 160